From a clinical perspective, METTL13 is clearly linked to key cancer hallmarks and recent evidence suggests that combined targeting of METTL13 and key cellular signaling pathways may represent an effective therapeutic strategy in cancer management. The gene discussed is METTL13; the disease is cancer.